Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Covid-19 booster vaccine programme to begin next week

The UK government today (September 14) announced the nine groups that are most vulnerable to Covid-19 will be eligible for a third booster dose of vaccine, six months after their second dose.

Health and Social Care secretary Sajid Javid told the Commons that the government has accepted the advice of the Joint Committee on Vaccination and Immunisation (JCVI) on booster jabs, and the NHS is preparing to offer Covid booster vaccine from next week.


Under the booster programme around 30 million people are likely to be offered a third dose.

More than 112,000 lives were saved and 24 million cases were averted because of Covid-19 vaccines, British officials said while recommending a booster shot for all vulnerable people, earlier today.

In its recommendation to the government, the JCVI has given preference to the Pfizer-BioNTech vaccine for the booster programme or alternatively a half-dose of a Moderna shot.

The committee has advised administering booster jab to those living in residential care homes for older adults, adults aged 50 years or over, frontline health and social care workers, adult contacts of immunosuppressed individuals and all those aged 16 to 49 years with serious health condition.

The advice comes ahead of an announcement by the government on its strategy for taming infections during this winter.

Professor Wei Shen Lim, chair of Covid-19 immunisation for the JCVI, said, “the main aim of the booster programme is to prolong that protection and reduce serious disease as we head towards the colder months.

“The JCVI is advising that a booster dose be offered to the more vulnerable, to maximise individual protection ahead of an unpredictable winter. Most of these people will also be eligible for the annual flu vaccine and we strongly advise them to take up this offer as well.”

Commenting on the Covid-19 vaccination booster programme announcement, Ruth Rankine, director of primary care at the NHS Confederation, said: “Our members will welcome confirmation of this final decision following weeks of uncertainty about the plans. Primary care has played a crucial part in the highly successful roll out of the vaccination programme to date and will continue to deliver to protect their patients and the public.”

She, however, noted that delivering booster programme along with the government’s recent decision to vaccinate 12–15-year-olds will require more time and investment.

She said: “we must also acknowledge the amount of time and investment that will be needed to deliver both these programmes alongside the flu vaccination programme, set against what is already an extremely busy time with primary care seeing a huge increase in demand coupled with increasingly complex cases, and managing patients waiting for secondary care treatment.”

More For You

Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Primary care leaders join forces in effort to 'transform investment into primary care'

Community Pharmacy England (CPE) has teamed up with other national primary care bodies to urge the government to allocate more funds towards the sector.

In a joint statement released on the back of the government’s spending review, last week, the organisations welcomed the government’s continued determination to ‘shift care from hospitals to community and from sickness to prevention’ but warned that this would not be possible ‘without further investment in primary care’.

Keep ReadingShow less
Cancer patients warned against using weight-loss jabs

Macmillan Cancer Support said there is not enough evidence on how the weight-loss jabs might affect anti-cancer treatments.

iStock

Cancer patients warned against using weight-loss jabs

Cancer patients have been advised to consult their doctor before taking any weight-loss jabs.

Macmillan Cancer Support has issued this advisory following a surge in calls by cancer patients asking whether they can take fat loss jabs such as Wegovy and Mounjaro.

Keep ReadingShow less
Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology

The FLOWRx auto hub in the new Kamson warehouse in Uckfield.

Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology


Kamsons Pharmacy has announced that it has implemented a state-of-the-art hub and spoke dispensing model with the aim of freeing up more time to deliver clinical services.

Keep ReadingShow less
RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less
Older adult organizing medicine bottles in a cool, dry storage area during warm weather.

People are being advised to keep medicine below 25° C

Pic credit: iStock

Pharmacies advise patients on storing medicines safely during heatwave

Patients are being given important advice and guidance on the impact heat can have on their medicine and where to keep different medicines as the UK goes through a heatwave.

People are being advised to keep medicine below 25° C if they are able to, unless storage instructions state it needs to be kept at an alternative temperature, such as drugs that need to be refrigerated.

Keep ReadingShow less